Literature DB >> 24143915

Work disability in Finnish patients with rheumatoid arthritis: a 15-year follow-up.

Tarja Tiippana-Kinnunen1, Leena Paimela, Ritva Peltomaa, Hannu Kautiainen, Leena Laasonen, Marjatta Leirisalo-Repo.   

Abstract

OBJECTIVES: To investigate long-term work disability of patients with early rheumatoid arthritis (RA) and to examine impact of early disease activity and radiological progression on the loss of final work capacity.
METHODS: Work disability due to RA was studied over 15 years in 86 Finnish patients with early RA and available for the labour force at study entry. RA-related retirement was studied in relation to early disease activity defined as the 28-joint disease activity score area under curve (DAS28 AUC) during the first 12 months and the impact of early radiological progression from the baseline to year 1.
RESULTS: The RA-related retirement rate was 7% after the first year, 11% after 2 years, 19% after 5 years, 33% after 10 years and 39% after 15 years. Of the patients with low disease activity (DAS28 AUC ≤3.2) none were retired during the first 3 years. The retirement rate was also lower in subsequent years (10% after 5 years, 14% after 10 years, and 27% after 15 years) among these patients compared to those with DAS28 AUC >3.2 (28%, 55%, and 64%, respectively). A similar trend was evident among patients with no radiological progression (≤1 unit increase in Larsen score) and those with >1 Larsen unit of progression during the first year of RA.
CONCLUSIONS: Our study suggests that low disease activity and halting of radiological progression during the first year of the disease improve possibilities to maintain work capacity in RA during the subsequent 15 years.

Entities:  

Mesh:

Year:  2013        PMID: 24143915

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  6 in total

1.  Impact of vasculitis on employment and income.

Authors:  Lillian Barra; Renée L Borchin; Cristina Burroughs; George C Casey; Carol A McAlear; Antoine G Sreih; Kalen Young; Peter A Merkel; Christian Pagnoux
Journal:  Clin Exp Rheumatol       Date:  2018-01-10       Impact factor: 4.473

2.  Explaining the gap in the experience of depression among arthritis patients.

Authors:  Manasi M Mittinty; James M Elliott; David J Hunter; Michael K Nicholas; Lyn M March; Murthy N Mittinty
Journal:  Clin Rheumatol       Date:  2022-01-07       Impact factor: 2.980

3.  Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider.

Authors:  Mary Lucy Marques; Alessia Alunno; Sofia Ramiro; Polina Putrik; Annelies Boonen; Marieke M Ter Wee; Louise Falzon
Journal:  RMD Open       Date:  2021-02

4.  A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA).

Authors:  Raluca B Dumitru; Sarah Horton; Richard Hodgson; Richard J Wakefield; Elizabeth M A Hensor; Paul Emery; Maya H Buch
Journal:  BMC Musculoskelet Disord       Date:  2016-02-05       Impact factor: 2.362

5.  Depression is a stronger predictor of the risk to consider work disability in early arthritis than disease activity or response to therapy.

Authors:  Johanna Callhoff; Katinka Albrecht; Georg Schett; Angela Zink; Gisela Westhoff
Journal:  RMD Open       Date:  2015-02-20

6.  Electromyographic Activity of the Upper Limb in Three Hand Function Tests.

Authors:  Natália Sanches Silva; Pedro Henrique Tavares Queiroz de Almeida; Paulo Vinicius Braga Mendes; Caio Sadao Medeiros Komino; José Marques Novo Jùnior; Daniel Marinho Cezar Da Cruz
Journal:  Hong Kong J Occup Ther       Date:  2017-02-16       Impact factor: 0.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.